U.S. Software Stock News

If you are trying to work out whether Caris Life Sciences at around US$18.20 is a bargain or a value trap, you are in the right place. The stock has been under pressure recently, with a 12.5% decline over the last 7 days, a 27.2% decline over the last 30 days, and a 32.5% decline year to date. Recent attention around Caris Life Sciences has focused on its position in the pharmaceuticals and biotech space and how investors are reassessing risk in the sector. This backdrop helps explain why...

If you are wondering whether Danaos is still good value after its recent run, you are in the right place. This article focuses squarely on what you are paying for each dollar of the business. The stock last closed at US$111.57, with returns of 4.0% over 7 days, 10.8% over 30 days, 17.1% year to date, 41.5% over 1 year and 116.4% over 3 years. These figures naturally raise questions about how much upside or risk is now priced in. Recent coverage of Danaos has highlighted its role in the...

Concentra Group Holdings Parent: Recent Moves In Context With no single headline event driving attention to Concentra Group Holdings Parent (CON), investors are focusing on how its recent share performance and financial profile fit into the occupational health services story. See our latest analysis for Concentra Group Holdings Parent. At a share price of $23.41, Concentra Group Holdings Parent has paired a 1 month share price return of 8.63% with a year to date share price return of 20.61%...

If you are wondering whether Regal Rexnord’s current share price really reflects what the business is worth, you are not alone. This article is built to help you assess that question clearly. With the stock at US$223.69 and returns of 2.1% over 7 days, 43.3% over 30 days, 53.1% year to date and 69.7% over 1 year, many investors are asking what is already priced in and what might still be on the table in terms of risk and reward. These moves sit against a backdrop where Regal Rexnord...

If you are wondering whether Knowles is fairly priced at around US$28.07 per share, you are not alone. This article will focus squarely on what that means for value minded investors. The stock has posted returns of 3.4% over the past week, 17.3% over the last 30 days, 27.9% year to date, 62.5% over 1 year and 65.3% over 3 years, with a 5 year return of 32.8%. This naturally raises questions about what is already reflected in the price. Recent coverage around Knowles has centered on its...

Analysts are flagging anticipated revenue declines for Fortive, citing softer demand and slower organic growth expectations. This shift in sentiment follows previously solid quarterly results and points to a possible inflection in the company’s operational outlook. The change comes as investors reassess Fortive’s near term growth profile beyond recent share price moves. For investors watching Fortive, ticker NYSE:FTV, the backdrop is a mix of steady share performance and growing questions...

Array Digital Infrastructure (NYSE:AD) has completed a transformation by selling its wireless operations and related spectrum assets. The company transferred spectrum holdings to major carriers, including T-Mobile and AT&T, and repositioned itself as a focused tower operator. Array Digital Infrastructure secured new long term Master License Agreements with top telecom companies for tower usage. The company distributed special dividends and outlined plans to invest further in its...

SI-BONE (SIBN) has wrapped up FY 2025 with Q4 revenue of about US$56.4 million and a basic EPS loss of US$0.04, alongside a trailing twelve month revenue base of roughly US$200.9 million and a TTM EPS loss of US$0.44. Over the past six quarters, revenue has moved from US$40.3 million in Q3 2024 to US$56.4 million in Q4 2025. Over the same period, quarterly basic EPS has ranged from a loss of US$0.16 in Q3 2024 to a loss of US$0.04 in the latest quarter, presenting a picture of expanding scale...

Dillard's (DDS) closed out FY 2026 with fourth quarter revenue of US$1,989.4 million and basic EPS of US$13.06, alongside net income of US$203.7 million. Earlier quarters showed revenue between US$1,490.97 million and US$1,546.97 million and EPS ranging from US$4.66 to US$10.39. Over the past year, the company reported trailing twelve month revenue of US$6.6 billion with basic EPS of US$36.32 and net income of US$570.2 million. These figures may prompt investors to focus closely on how...

Constellation Energy (CEG) has wrapped up FY 2025 with Q4 revenue of US$6.1b, Basic EPS of US$1.38 and net income of US$432m, putting a concrete set of numbers behind the recent share price of US$312.64. The company has seen quarterly revenue range between US$6.1b and US$6.8b across FY 2025, while Basic EPS moved from US$0.38 in Q1 to US$2.97 in Q3 before landing at US$1.38 in Q4, giving investors a clear view of how profit per share has shifted through the year. With trailing 12 month net...

Bank of Hawaii (NYSE:BOH) has announced that its CEO plans to retire at the end of March 2026. A board member recently executed a substantial sale of Bank of Hawaii shares. These leadership and ownership changes come as the stock last closed at $76.83. For investors watching Bank of Hawaii, the combination of a planned CEO retirement and a large board member share sale puts the focus squarely on governance and continuity. NYSE:BOH last closed at $76.83, with the stock showing returns of...

Vaxcyte (NasdaqGS:PCVX) has launched a comprehensive Phase 3 adult clinical program for its VAX-31 pneumococcal conjugate vaccine. The company has completed enrollment in a Phase 2 study of VAX-31 in infants. Vaxcyte is preparing to advance a separate vaccine candidate targeting Group A Streptococcus. These moves follow FDA alignment and an expanded Breakthrough Therapy designation for VAX-31. Vaxcyte, trading at about $61.35, is moving into a more mature stage of its pipeline, with VAX-31...

If you are wondering whether Primo Brands at around US$19.36 is a bargain or a value trap, you are not alone. This article is designed to help you frame that question clearly. The stock has seen mixed returns, with a 5.9% move over the last 7 days, 0.5% over 30 days, 19.6% year to date, a 41.6% decline over 1 year, and gains of 36.6% and 48.2% over 3 and 5 years respectively. These figures can change how investors think about both upside and risk. Recent news coverage around Primo Brands has...

Oncolytics Biotech (ONCY) has attracted fresh attention after a recent move in its share price, with the stock closing at US$1.13 and showing mixed return patterns across the past year and over multiple years. See our latest analysis for Oncolytics Biotech. The recent 6.6% 1 day share price return and 10.8% 7 day share price return suggest short term momentum is building around Oncolytics Biotech, even as the 58.3% 1 year total shareholder return contrasts with weaker 3 and 5 year total...

Preferred Bank reclassified a sizable loan relationship from substandard to nonaccrual status following ongoing legal complications involving the borrower’s principals. The borrower is facing complex lawsuits that have contributed to cash flow pressures and payment issues on the loan. Management has indicated that, based on current expectations, the ultimate resolution of this credit is not expected to significantly affect 2026 earnings. For you as an investor following NasdaqGS:PFBC, this...

Boise Cascade (BCC) has wrapped up FY 2025 with Q4 revenue of US$1.5 billion and basic EPS of US$0.24, alongside trailing twelve month revenue of US$6.4 billion and EPS of US$3.54 that frame the current run rate. The company has seen quarterly revenue range from US$1.5 billion to US$1.7 billion across 2025, with basic EPS moving from US$1.06 in Q1 and US$1.64 in Q2 to US$0.58 in Q3 and US$0.24 in Q4. This puts the spotlight squarely on how sustainably Boise Cascade can defend its margins from...

Curbline Properties Corp., a self-managed REIT trading under the symbol CURB, recently declared its first quarter 2026 common stock dividend of US$0.17 per share, a 6% increase from the fourth quarter 2025 payout, payable on April 8, 2026 to shareholders of record on March 18, 2026. This higher dividend highlights management’s willingness to return more cash to investors, which may be interpreted as confidence in the REIT’s ability to support its current payout level. We’ll now examine how...

Skyward Specialty Insurance Group (SKWD) closed out FY 2025 with fourth quarter revenue of US$385.6 million and basic EPS of US$1.07, while trailing twelve month revenue reached about US$1.4 billion and EPS came in at US$4.21. The company reported revenue increasing from US$304.4 million in Q4 2024 to US$385.6 million in Q4 2025, with basic EPS rising from US$0.36 to US$1.07 over the same period. These figures frame a situation in which investors may compare the company’s earnings power with...

What the recent performance says about Farmers & Merchants Bank of Long Beach (FMBL) Farmers & Merchants Bank of Long Beach (FMBL) has quietly posted positive returns over several time frames, including the past week, month and past 3 months, alongside a 1 year total return above 50%. For a thinly traded regional bank founded in 1907 and focused on Southern California customers, these moves give you a reason to look more closely at how its current share price lines up with recent business...

If you are wondering whether Hancock Whitney is still good value after its recent run, the stock's current setup makes a closer look at its valuation especially relevant. The share price sits at US$67.67, with returns of 5.0% year to date and 23.9% over the last year, in addition to longer term gains of 50.7% over 3 years and 95.7% over 5 years. However, the stock has seen a 4.4% decline over the past week and a modest 0.7% move over the past month. Recent coverage of Hancock Whitney has...

Vistance Networks (NasdaqGS:VISN) has completed a major divestiture and rebranded its business focus. The company has closed a significant shelf registration and is shifting priorities toward debt elimination. Management has outlined plans to begin returning cash to shareholders through dividends. For investors watching Vistance Networks, these moves mark a clear reset in how the company is positioned and financed. The stock last closed at $17.95, with a 1-year return of 267.1% and a 3-year...

Addus HomeCare (ADUS) closed out FY 2025 with fourth quarter revenue of US$373.1 million and basic EPS of US$1.61, while trailing twelve month figures reached US$1.4b in revenue and US$5.22 in EPS. The company has seen quarterly revenue move from US$297.1 million in Q4 2024 to US$373.1 million in Q4 2025, and basic EPS rise from US$1.07 to US$1.61 over the same period. This ties into a year of 30.3% earnings growth supported by a 6.7% net margin. For investors, this combination of higher...

If you are wondering whether Dorchester Minerals is priced fairly today, you are not alone. Many investors are asking if the current unit price really reflects its underlying value. The stock has had mixed returns, with a 0.6% move over the last 7 days, 3.7% over 30 days, 9.5% year to date, but a 7.6% decline over the past year and a very large gain over 5 years that points to a very different longer term picture. Recent attention on Dorchester Minerals has focused on its role as a royalty...

Adeia FY 2025 results put sharp Q4 finish under the microscope Adeia (ADEA) closed FY 2025 with Q4 revenue of US$182.6 million and basic EPS of US$0.68, setting a clear marker for how the year wrapped up. Over the past six quarters, the company has seen quarterly revenue move between US$85.7 million and US$182.6 million, while basic EPS ranged from US$0.08 to US$0.68. Trailing twelve month EPS reached US$1.02 on revenue of US$443.4 million. With earnings up 71.9% over the last year and net...